Loading…

Type I interferon signaling in fibroblastic reticular cells prevents exhaustive activation of antiviral CD8 + T cells

Fibroblastic reticular cells (FRCs) are stromal cells that actively promote the induction of immune responses by coordinating the interaction of innate and adaptive immune cells. However, whether and to which extent immune cell activation is determined by lymph node FRC reprogramming during acute vi...

Full description

Saved in:
Bibliographic Details
Published in:Science immunology 2020-09, Vol.5 (51)
Main Authors: Perez-Shibayama, Christian, Islander, Ulrika, Lütge, Mechthild, Cheng, Hung-Wei, Onder, Lucas, Ring, Sandra S, De Martin, Angelina, Novkovic, Mario, Colston, Julia, Gil-Cruz, Cristina, Ludewig, Burkhard
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fibroblastic reticular cells (FRCs) are stromal cells that actively promote the induction of immune responses by coordinating the interaction of innate and adaptive immune cells. However, whether and to which extent immune cell activation is determined by lymph node FRC reprogramming during acute viral infection has remained unexplored. Here, we genetically ablated expression of the type I interferon-α receptor ( ) in Ccl19-Cre cells and found that sensing of type I interferon imprints an antiviral state in FRCs and thereby preserves myeloid cell composition in lymph nodes of naive mice. During localized lymphocytic choriomeningitis virus infection, IFNAR signaling precipitated profound phenotypic adaptation of all FRC subsets enhancing antigen presentation, chemokine-driven immune cell recruitment, and immune regulation. The IFNAR-dependent shift of all FRC subsets toward an immunostimulatory state reduced exhaustive CD8 T cell activation. In sum, these results unveil intricate circuits underlying type I IFN sensing in lymph node FRCs that enable protective antiviral immunity.
ISSN:2470-9468
2470-9468
DOI:10.1126/SCIIMMUNOL.ABB7066